Pharvaris (PHVS) Liabilities and Shareholders Equity (2020 - 2026)

Pharvaris (PHVS) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $304.1 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $304.1 million; the trailing twelve-month figure through Mar 2026 stood at $966.4 million (up 6.03% YoY), and the FY2025 full-year result was $340.6 million, up 8.0% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $304.1 million, down from $350.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $429.0 million in Q4 2023 and bottomed at $171.1 million in Q4 2022.
• The 5-year median for Liabilities and Shareholders Equity is $311.4 million (2024), against an average of $313.3 million.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity dropped 29.47%; it then soared 150.67% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $171.1 million in 2022, then soared by 150.67% to $429.0 million in 2023, then retreated by 27.42% to $311.4 million in 2024, then climbed by 12.7% to $350.9 million in 2025, then dropped by 13.33% to $304.1 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $304.1 million (Q1 2026), $350.9 million (Q4 2025), and $311.4 million (Q4 2024), per Business Quant data.

Peer Comparison